REFERENCES
- Ito S, Barrett AJ. Gauchers disease –a reappraisal of hematopoietic stem cell transplantation. Pediatr Hematol Oncol. 2013;30:61–70.
- Zimran A. How I treat Gaucher disease. Blood. 2011;118:1463–1471.
- Ringden O, Groth CG, Erikson A, Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease. Transplantation. 1988;46:66–70.
- Hobbs JR, Jones KH, Shaw PJ, Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome. Lancet. 1987;1:1111–1115.
- Ringden O, Groth CG, Erikson A, Ten years’ experience of bone marrow transplantation for Gaucher disease. Transplantation. 1995;59:864–870.
- Dahl N, Lagerstrom M, Erikson A, Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet. 1990;47:275–278.
- Hruska KS, LaMarca ME, Scott CR, Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008;29:567–583.
- Machaczka M, Hast R, Dahlman I, Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution. Ups J Med Sci. 2012;117:28–34.
- Dreborg S, Erikson A, Hagberg B. Gaucher disease –Norrbottnian type. I. General clinical description. Eur J Pediatr. 1980;133:107–118.
- Ringden O, Remberger M, Svahn BM, Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center. Transplantation. 2006;81:718–725.